Journal article
Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection
- Abstract:
- <h4>Objective</h4>HIV-associated chronic lung disease (HCLD) is a common comorbidity in children and adolescents in sub-Saharan Africa (SSA). The pathogenesis of HCLD is unclear and may be driven by underlying dysregulated systemic immune activation and inflammation. We investigated the association between 26 plasma soluble biomarkers and HCLD.<h4>Design</h4>Case--control analysis of baseline biomarker data from 336 children and adolescents (6-19 years old) with perinatal HIV infection (PHIV) and HCLD (cases) and 74 age-matched and sex-matched controls with PHIV but no CLD. HCLD was defined as having a forced expiratory volume in one second (FEV1) z score less than -1 with no reversibility.<h4>Methods</h4>Cryopreserved plasma collected at recruitment was used in a multiplex bead assay (Luminex) to measure baseline levels of soluble biomarkers. Logistic regression alongside data-reduction and techniques quantifying the interconnectedness of biomarkers were used to identify biomarkers associated with odds of HCLD.<h4>Results</h4>Biomarkers of general immune activation and inflammation (β2M, CRP, sCCL5, GCSF, IFN-γ, IP-10), T-cell activation (sCD25, sCD27), platelet activation (sCD40-L), monocyte activation (sCD14), coagulation (D-Dimer), cellular adhesion (E-selectin), and extracellular matrix degradation (MMP-1, MMP-7, MMP-10) were associated with increased odds of HCLD. Exploratory PCA and assessment of biomarker interconnectedness identified T-cell and platelet activation as centrally important to this association.<h4>Conclusion</h4>HCLD was associated with a large number of soluble biomarkers representing a range of different pathways. Our findings suggest a prominent role for T-cell and platelet activation in HCLD.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 2.4MB, Terms of use)
-
- Publisher copy:
- 10.1097/qad.0000000000002964
Authors
- Publisher:
- Lippincott, Williams and Wilkins
- Journal:
- AIDS More from this journal
- Volume:
- 35
- Issue:
- 11
- Pages:
- 1743-1751
- Publication date:
- 2021-06-03
- Acceptance date:
- 2021-05-21
- DOI:
- EISSN:
-
1473-5571
- ISSN:
-
0269-9370
- Pmid:
-
34074817
- Language:
-
English
- Keywords:
- Pubs id:
-
1180512
- Local pid:
-
pubs:1180512
- Deposit date:
-
2021-08-13
- ARK identifier:
Terms of use
- Copyright holder:
- Wolters Kluwer Health
- Copyright date:
- 2021
- Rights statement:
- © 2021 Wolters Kluwer Health, Inc. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Lippincott, Williams and Wilkins at: http://dx.doi.org/10.1097/qad.0000000000002964
If you are the owner of this record, you can report an update to it here: Report update to this record